2 Experimental Coronavirus Vaccines Move To Large-Scale Trials In Final Testing Phase

NPR: 2 Coronavirus Vaccines Move To Final Testing Phase
“Two companies announced [Monday] that they are beginning widespread testing of potential coronavirus vaccines. One comes from a collaboration between the National Institutes of Health and the U.S. biotech company Moderna. The other is from a collaboration between the pharmaceutical giant Pfizer and the German biotech company BioNTech. Each trial needs 30,000 volunteers…” (Palca, 7/27).

Additional coverage of the vaccine trials and related news is available from AP, Business Insider, Financial Times, The Hill, Newsweek, New York Times, Science Speaks, STAT, and Wall Street Journal (2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.